SLC5A2 and chronic kidney disease: Effects of Sodium-glucose cotransporters 2 (SGLT2) inhibitors on estimated glomerular filtration rate (eGFR) in randomized controlled trials (RCTs) in patients with type 2 diabetes and chronic kidney disease (CKD) of different levels.